0001423173-11-000002.txt : 20110309 0001423173-11-000002.hdr.sgml : 20110309 20110309120717 ACCESSION NUMBER: 0001423173-11-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20110309 DATE AS OF CHANGE: 20110309 EFFECTIVENESS DATE: 20110309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROPHAGE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001423173 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-156414 FILM NUMBER: 11674240 BUSINESS ADDRESS: STREET 1: 1600 MASSACHUSETTS AVENUE STREET 2: SUITE 702 CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 617-714-3947 MAIL ADDRESS: STREET 1: 1600 MASSACHUSETTS AVENUE STREET 2: SUITE 702 CITY: CAMBRIDGE STATE: MA ZIP: 02138 D 1 primary_doc.xml X0704 D LIVE 0001423173 NEUROPHAGE PHARMACEUTICALS INC 222 THIRD STREET SUITE 3120 CAMBRIDGE MA MASSACHUSETTS 02142 (617) 714-5468 DELAWARE None None Corporation true 2006 Hampus Hillerstrom c/o Neurophage Pharmaceuticals, Inc. 222 Third Street, Suite 3120 Cambridge MA MASSACHUSETTS 02142 Executive Officer Vicki Sato c/o NeuroPhage Pharmaceuticals, Inc. 222 Third Street, Suite 3120 Cambridge MA MASSACHUSETTS 02142 Director Jonathan Solomon c/o NeuroPhage Pharmaceuticals, Inc. 222 Third Street, Suite 3120 Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Mark Skaletsky c/o NeuroPhage Pharmaceuticals, Inc. 222 Third Street, Suite 3120 Cambridge MA MASSACHUSETTS 02142 Director Paul Goldenheim c/o NeuroPhage Pharmaceuticals, Inc. 222 Third Street, Suite 3120 Cambridge MA MASSACHUSETTS 02142 Director Valerie Calenda c/o NeuroPhage Pharmaceuticals, Inc. 222 Third Street, Suite 3120 Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06 false 2011-02-18 false true true true false 0 12425671 8430327 3995344 false 32 0 0 0 false NEUROPHAGE PHARMACEUTICALS INC /s/Hampus Hillerstrom Hampus Hillerstrom Executive VP 2011-03-07